Literature DB >> 34360948

The Development of Molecular Biology of Osteoporosis.

Yongguang Gao1, Suryaji Patil2, Jingxian Jia1.   

Abstract

Osteoporosis is one of the major bone disorders that affects both women and men, and causes bone deterioration and bone strength. Bone remodeling maintains bone mass and mineral homeostasis through the balanced action of osteoblasts and osteoclasts, which are responsible for bone formation and bone resorption, respectively. The imbalance in bone remodeling is known to be the main cause of osteoporosis. The imbalance can be the result of the action of various molecules produced by one bone cell that acts on other bone cells and influence cell activity. The understanding of the effect of these molecules on bone can help identify new targets and therapeutics to prevent and treat bone disorders. In this article, we have focused on molecules that are produced by osteoblasts, osteocytes, and osteoclasts and their mechanism of action on these cells. We have also summarized the different pharmacological osteoporosis treatments that target different molecular aspects of these bone cells to minimize osteoporosis.

Entities:  

Keywords:  bone remodeling; bone therapeutics; osteoblasts; osteoclasts; osteocytes; osteoporosis

Year:  2021        PMID: 34360948     DOI: 10.3390/ijms22158182

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  10 in total

1.  STK11 overexpression prevents glucocorticoid-induced osteoporosis via activating the AMPK/SIRT1/PGC1α axis.

Authors:  Jiao Xiao; Wenjin Li; Guojuan Li; Jiankai Tan; Na Dong
Journal:  Hum Cell       Date:  2022-05-11       Impact factor: 4.174

2.  LncRNA BC083743 Silencing Exacerbated Osteoporosis by Regulating the miR-103-3p/SATB2 Axis to Inhibit Osteogenic Differentiation.

Authors:  Feng Lu; Ling Tang
Journal:  Comput Intell Neurosci       Date:  2022-06-20

3.  MicroRNA‑141 inhibits the differentiation of bone marrow‑derived mesenchymal stem cells in steroid‑induced osteonecrosis via E2F3.

Authors:  Fei Xue; Jian Wu; Wei Feng; Ting Hao; Yuan Liu; Wenbo Wang
Journal:  Mol Med Rep       Date:  2022-05-26       Impact factor: 3.423

4.  Imatinib has minimal effects on inflammatory and osteopenic phenotypes in a murine cherubism model.

Authors:  Tomoyuki Mukai; Takahiko Akagi; Sumie Hiramatsu Asano; Ikue Tosa; Mitsuaki Ono; Mizuho Kittaka; Yasuyoshi Ueki; Ayano Yahagi; Masanori Iseki; Toshitaka Oohashi; Katsuhiko Ishihara; Yoshitaka Morita
Journal:  Oral Dis       Date:  2021-11-07       Impact factor: 4.068

Review 5.  Exercise and Nutrition Impact on Osteoporosis and Sarcopenia-The Incidence of Osteosarcopenia: A Narrative Review.

Authors:  Sousana K Papadopoulou; Konstantinos Papadimitriou; Gavriela Voulgaridou; Evridiki Georgaki; Eudoxia Tsotidou; Olga Zantidou; Dimitrios Papandreou
Journal:  Nutrients       Date:  2021-12-16       Impact factor: 5.717

Review 6.  Structural and Metabolic Changes in Bone.

Authors:  Agata Wawrzyniak; Krzysztof Balawender
Journal:  Animals (Basel)       Date:  2022-07-31       Impact factor: 3.231

Review 7.  Current Status of the Diagnosis and Management of Osteoporosis.

Authors:  Agustín Aibar-Almazán; Ana Voltes-Martínez; Yolanda Castellote-Caballero; Diego Fernando Afanador-Restrepo; María Del Carmen Carcelén-Fraile; Elena López-Ruiz
Journal:  Int J Mol Sci       Date:  2022-08-21       Impact factor: 6.208

8.  KYMASIN UP Natural Product Inhibits Osteoclastogenesis and Improves Osteoblast Activity by Modulating Src and p38 MAPK.

Authors:  Laura Salvadori; Maria Laura Belladonna; Beatrice Castiglioni; Martina Paiella; Eleonora Panfili; Tommaso Manenti; Catia Ercolani; Luca Cornioli; Sara Chiappalupi; Giulia Gentili; Massimiliano Leigheb; Guglielmo Sorci; Michela Bosetti; Nicoletta Filigheddu; Francesca Riuzzi
Journal:  Nutrients       Date:  2022-07-25       Impact factor: 6.706

9.  Maresin1 Suppresses High-Glucose-Induced Ferroptosis in Osteoblasts via NRF2 Activation in Type 2 Diabetic Osteoporosis.

Authors:  Zhanwei Zhang; Chonghao Ji; Ya-Nan Wang; Shiyue Liu; Maoshan Wang; Xin Xu; Dongjiao Zhang
Journal:  Cells       Date:  2022-08-17       Impact factor: 7.666

Review 10.  Inflammation and Bone Metabolism in Rheumatoid Arthritis: Molecular Mechanisms of Joint Destruction and Pharmacological Treatments.

Authors:  Kazuhiro Maeda; Ken Yoshida; Tetsuro Nishizawa; Kazuhiro Otani; Yu Yamashita; Hinako Okabe; Yuka Hadano; Tomohiro Kayama; Daitaro Kurosaka; Mitsuru Saito
Journal:  Int J Mol Sci       Date:  2022-03-06       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.